Acetyl Sulfisoxazole
The metabolism of Mebendazole can be decreased when combined with Acetyl sulfisoxazole.
Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Mebendazole.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Mebendazole.
Advertisement
Amiodarone
The metabolism of Mebendazole can be decreased when combined with Amiodarone.
Amodiaquine
The serum concentration of Mebendazole can be decreased when it is combined with Amodiaquine.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Mebendazole.
Advertisement
Apalutamide
The serum concentration of Mebendazole can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Mebendazole can be increased when it is combined with Aprepitant.
Atazanavir
The metabolism of Mebendazole can be decreased when combined with Atazanavir.
Advertisement
Atomoxetine
The metabolism of Mebendazole can be decreased when combined with Atomoxetine.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Mebendazole.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Mebendazole.
Boceprevir
The metabolism of Mebendazole can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Mebendazole can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Mebendazole can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Mebendazole can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Mebendazole.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Mebendazole.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Mebendazole.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Mebendazole.
Carbamazepine
The serum concentration of Mebendazole can be decreased when it is combined with Carbamazepine.
Ceritinib
The serum concentration of Mebendazole can be increased when it is combined with Ceritinib.
Chloroquine
The serum concentration of Mebendazole can be decreased when it is combined with Chloroquine.
Cimetidine
The serum concentration of Mebendazole can be increased when it is combined with Cimetidine.
Clarithromycin
The metabolism of Mebendazole can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Mebendazole can be decreased when combined with Clemastine.
Clotrimazole
The metabolism of Mebendazole can be decreased when combined with Clotrimazole.
Cobicistat
The metabolism of Mebendazole can be decreased when combined with Cobicistat.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Mebendazole.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Mebendazole.
Crizotinib
The metabolism of Mebendazole can be decreased when combined with Crizotinib.
Curcumin
The metabolism of Mebendazole can be decreased when combined with Curcumin.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Mebendazole.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Mebendazole.
Cyclosporine
The metabolism of Mebendazole can be decreased when combined with Cyclosporine.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Mebendazole.
Dabrafenib
The serum concentration of Mebendazole can be decreased when it is combined with Dabrafenib.
Darunavir
The metabolism of Mebendazole can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Mebendazole can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Mebendazole can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Mebendazole can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Mebendazole can be decreased when combined with Delavirdine.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Mebendazole.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Mebendazole.
Digoxin
Digoxin may decrease the cardiotoxic activities of Mebendazole.
Dihydroergotamine
The metabolism of Mebendazole can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Mebendazole can be decreased when combined with Diltiazem.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Mebendazole.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Mebendazole.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Mebendazole.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Mebendazole.
Doxycycline
The metabolism of Mebendazole can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Mebendazole can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Mebendazole can be decreased when combined with Dronedarone.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Mebendazole.
Enzalutamide
The serum concentration of Mebendazole can be decreased when it is combined with Enzalutamide.
Erythromycin
The metabolism of Mebendazole can be decreased when combined with Erythromycin.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Mebendazole.
Fluconazole
The metabolism of Mebendazole can be decreased when combined with Fluconazole.
Fluvoxamine
The metabolism of Mebendazole can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Mebendazole can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Mebendazole can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The serum concentration of Mebendazole can be decreased when it is combined with Fosphenytoin.
Fusidate
The serum concentration of Mebendazole can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Mebendazole can be increased when it is combined with Fusidic Acid.
Hydroxychloroquine
The serum concentration of Mebendazole can be decreased when it is combined with Hydroxychloroquine.
Hypoxis hemerocallidea root extract
The serum concentration of Mebendazole can be decreased when it is combined with St. John's Wort.
Idelalisib
The metabolism of Mebendazole can be decreased when combined with Idelalisib.
Imatinib
The metabolism of Mebendazole can be decreased when combined with Imatinib.
Indinavir
The metabolism of Mebendazole can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Mebendazole can be decreased when combined with Indinavir.
Isavuconazole
The serum concentration of Mebendazole can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Mebendazole can be decreased when combined with Isavuconazonium.
Isradipine
The metabolism of Mebendazole can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Mebendazole can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Mebendazole can be increased when it is combined with Ivacaftor.
Ketoconazole
The metabolism of Mebendazole can be decreased when combined with Ketoconazole.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Mebendazole.
Lopinavir
The metabolism of Mebendazole can be decreased when combined with Lopinavir.
Lovastatin
The metabolism of Mebendazole can be decreased when combined with Lovastatin.
Luliconazole
The serum concentration of Mebendazole can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Mebendazole can be increased when combined with Lumacaftor.
Metronidazole
The risk or severity of adverse effects can be increased when Mebendazole is combined with Metronidazole.
Mifepristone
The serum concentration of Mebendazole can be increased when it is combined with Mifepristone.
Mitotane
The serum concentration of Mebendazole can be decreased when it is combined with Mitotane.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Mebendazole.
Nefazodone
The metabolism of Mebendazole can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Mebendazole can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Mebendazole can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Mebendazole can be increased when combined with Nevirapine.
Nilotinib
The metabolism of Mebendazole can be decreased when combined with Nilotinib.
Olaparib
The metabolism of Mebendazole can be decreased when combined with Olaparib.
Osimertinib
The serum concentration of Mebendazole can be increased when it is combined with Osimertinib.
Ouabain
Ouabain may decrease the cardiotoxic activities of Mebendazole.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Mebendazole.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Mebendazole.
Palbociclib
The serum concentration of Mebendazole can be increased when it is combined with Palbociclib.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Mebendazole.
Pentobarbital
The metabolism of Mebendazole can be increased when combined with Pentobarbital.
Phenobarbital
The metabolism of Mebendazole can be increased when combined with Phenobarbital.
Phenytoin
The serum concentration of Mebendazole can be decreased when it is combined with Phenytoin.
Posaconazole
The metabolism of Mebendazole can be decreased when combined with Posaconazole.
Primaquine
The serum concentration of Mebendazole can be decreased when it is combined with Primaquine.
Primidone
The metabolism of Mebendazole can be increased when combined with Primidone.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Mebendazole.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Mebendazole.
Rifabutin
The metabolism of Mebendazole can be increased when combined with Rifabutin.
Rifampin
The metabolism of Mebendazole can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Mebendazole can be increased when combined with Rifapentine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Mebendazole.
Rucaparib
The metabolism of Mebendazole can be decreased when combined with Rucaparib.
Saquinavir
The metabolism of Mebendazole can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Mebendazole can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Mebendazole can be decreased when used in combination with Sarilumab.
Sildenafil
The metabolism of Mebendazole can be decreased when combined with Sildenafil.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Mebendazole.
Siltuximab
The serum concentration of Mebendazole can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Mebendazole can be increased when it is combined with Simeprevir.
ST. JOHN'S WORT EXTRACT
The serum concentration of Mebendazole can be decreased when it is combined with St. John's Wort.
Sulfisoxazole
The metabolism of Mebendazole can be decreased when combined with Sulfisoxazole.
Telaprevir
The metabolism of Mebendazole can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Mebendazole can be decreased when combined with Telithromycin.
Ticlopidine
The metabolism of Mebendazole can be decreased when combined with Ticlopidine.
Tocilizumab
The serum concentration of Mebendazole can be decreased when it is combined with Tocilizumab.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Mebendazole.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Mebendazole.
Vemurafenib
The serum concentration of Mebendazole can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Mebendazole can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Mebendazole can be decreased when combined with Verapamil.
Vincristine
The excretion of Vincristine can be decreased when combined with Mebendazole.
Voriconazole
The metabolism of Mebendazole can be decreased when combined with Voriconazole.
Ziprasidone
The metabolism of Mebendazole can be decreased when combined with Ziprasidone.
